Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-124882
Filing Date
2024-12-03
Accepted
2024-12-03 07:13:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2429853d2_defa14a.htm DEFA14A 48118
2 EXHIBIT 2.1 tm2429853d2_ex2-1.htm EX-2.1 562322
3 EXHIBIT 99.1 tm2429853d2_ex99-1.htm EX-99.1 36535
4 GRAPHIC tm2429853d1_ex99-1img001.jpg GRAPHIC 12526
  Complete submission text file 0001104659-24-124882.txt   665607
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 241521060
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)